Ginseng Intestinal Bacterial Metabolite IH901 as a New Anti-Metastatic Agent

  • Hideo Hasegawa (Itto Institute of Life Science Research, Happy World Inc, Department of Pathogenic Biochemistry, Research Institute for Wakan-yaku) ;
  • Sung, Jong-Hwan (Central Research Institute, IL HWA Co. Ltd) ;
  • Huh, Jae-Doo (Central Research Institute, IL HWA Co. Ltd)
  • Published : 1997.12.01

Abstract

Anti-metastatic activities of IH901, an intestinal bacterial metabolic derivative formed from Ginseng protopanaxadiol saponins, was determined in vitro and in vivo. Under in vitro conditions, IH901 inhibited the migration of bovine aortic endothelial cells 25 times stronger than suramin and suppressed the invasion of HT1080 human fibrosarcoma cells into reconstituted basement membrane components of Matrigel 1000 times stronger than RGDS peptide. IH901 also showed inhibitory effect on type-IV collagenase secretion from HT 1080 cells and platelet aggregation. When the anti-metastatic activity of IH901 was evaluated in comparison with that of 5-FU using a spontaneous lung metastatic model of Lewis lung carcinoma, the administration of IH901 (10 mg/kg p. o.) to tumor-bearing mice led to a significant decrease in lung metastasis (43% of untreated control), which was slightly more effective than that obtained with 5-FU (56% of control). Thus, IH901 seems to exhibit its anti-metastatic activity partly through the inhibition of tumor invasion which results from the blockade of type IV collagenase secretion and also through anti-platelet and anti-angiogenic activities.

Keywords

References

  1. Cancer invasion and metastases: Biologic and therapeutic aspects The Ernst W. Bernet memorial award lecture: the evolution of biological heterogeneity in metastatic neoplasms Fidler,I.J.;Nicolson,G.L.(ed.);Milas,L.(ed.)
  2. Cancer Res. v.52 Inhibition of angiogenesis by suramin Gagliardi,A.;Hadd,H.;Collins,D.C.
  3. Planta Med. v.60 Inhibitory effect of some triterpenoid saponins on glucose transport in tumor cells and its application to in vitro cytotoxic and antiviral activities Hasegawa,H.;Matsumiya,S.;Uchiyama,M.;Kurokawa,T.;Inouye,Y.;Kasai,R.;Ishibashi,S.;Yamasaki,K.
  4. Phytother. Res. v.9 Reversal of efflux-mediated tetracycline resistance in Staphylococcus aureus clinical isolates by Ginseng prosapogenins Hasagawa,H.;Matsumiya,S.;Uchiyama,M.;Inouye,Y.;Kasai,R.;Yamaski,K.
  5. Planta Med. v.61 Reversal of daunomycin and vinblastine resistance in multidrug-resistant P388 leukemia in vitro through enhanced cytotoxicity by triterpenoids Hasegawa,H.;Sung,J.H.;Matsumiya,S.;Uchiyama,M.;Inouye,Y.;Kasai,R.;Yamasaki,K.
  6. Planta Med. v.62 Main Ginseng saponin metabolites formed by intestinal bacteria Hasagawa,H.;Sung,J.H.;Matsumiya,S.;Uchiyama,M.
  7. Cancer Metastasis Rev. v.1 "Seed and soil" revisited: mechanisms of site specific metastasis Hart,I.R.
  8. Int. J. Cancer. v.63 Inhibition of metastasis of Lewis lung carcinoma by urinary trypsin inhibitor in experimental and spontaneous metastasis model Kobayashi,H.;Shinohara,H.;Fujie,M.;Gotoh,J.;Itoh,M.;Takeuchi,K.;Terao,T.
  9. Lab. Invest. v.49 Tumor invasion and the extracellular matrix Liotta,L.A.;Rao,C.V.;Barsky,S.H.
  10. Cancer Res. v.50 Tumor promotor-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: Isolation and characterization of the enzyme from HT1080 tumor cells Moll,U.M.;Youngeleib,G.L.;Rosinski,K.B.;Quigley,J.P.
  11. Cancer Res. v.47 Tumor cell instability, diverstification, and progression to the metastatic phenotype: from oncogene to oncofetal expression Nicolson,G.L.
  12. J. Clin. Pathol. v.15 Platelet aggregation O'Brien,J.R.
  13. Cancer Res. v.49 Inhibition of the metastasis of murine malignant melanoma by synthetic polymeric peptides containing core sequences of cell-adhesive molecules Saiki,I.;Iida,J.;Murata,J.;Ogawa,R.;Nishi,N.;Sugimura,K.;Tokura,S.;Azuma,I.
  14. Jpn. J. Cancer Res. v.80 Inhibition of tumor-cell invasion by ubenimex (bestatin) in vitro Saiki,I.;Murata,J.;Watanabe,K.;Fujii,H.;Abe,F.Azuma,I.
  15. J. Cell. Biol. v.107 Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis Sato,Y.;Rifkin,D.B.
  16. Cancer Res. v.46 Immunomodulatory and therapeutic properties of bestatin in mice Talmadge,J.E.;Lenz,B.F.;Pennington,R.;Long,C.;Phillips,H.;Schneider,M.;Tribble,H.
  17. Cancer Res. v.54 Matrix metalloprotease inhibitor BB-94 (Batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice Wang,X.;Fu,X.;Brown,P.D.;Crimmin,M.J.;Hoffman,R.M.